We understand that in the current situation colonoscopy testing has been restricted and access to laboratory calprotectin testing may be more difficult.
Since the BSG has recommended that only emergency colonoscopies are performed, we have collated some guidance to assist Clinicians on how to manage their symptomatic patients.
IBDoc® – Remote Management of Your IBD Patients
IBDoc® Tutorial Videos for Healthcare Professionals
The videos below from BÜHLMANN have been made to assist healthcare professionals with the IBDoc® system:
BÜHLMANN Quantum Blue® – Rapid, Individual Calprotectin Testing
BÜHLMANN calprotectin assays offer a range of testing options, including Quantum Blue® individual lateral flow tests for those urgent requests.
Although traditionally the Quantum Blue is a valuable tool for rapid testing in clinic, in the current COVID-19 situation this is probably best performed in the laboratory for the following reasons:
- Front line staff don’t have the capacity to perform additional tests at the moment
- It has been documented that the virus is shed in stool, so samples are best handled in the controlled environment of the laboratory
Quantum Blue can give you quantitative faecal calprotectin results in just 4 easy steps and can also easily be linked directly to your computer for quick data input, making it an ideal choice in an emergency situation.
There are three assay ranges available:
LF-CAL25 30 – 300µg/g
LF-CHR25 100 – 1800µg/g
LF-CALE25 30 – 1000µg/g
Each pack contains 25 individually sealed tests – therefore if you only want one test, then you only have to use one.
Quantum Blue® has a well documented correlation to clinical outcome:
“This rapid bedside test can facilitate clinical decisions on hospital admission, such as deciding whether the IBD treatment should be intensified. Similarly, in the ambulatory setting, it is crucial when determining whether a patient should undergo endoscopy or not.”
Moniuszko et al. Polish Archives of Internal Medicine 2017. Rapid fecal calprotectin test for prediction of mucosal inflammation in ulcerative colitis and Crohn’s disease: A prospective cohort study.
Click Here to Visit the Quantum Blue® Page to Find Out More
“Quantum Blue® provides high diagnostic accuracy and was less time consuming in clinical routine than quantification of faecal calprotectin by ELISA. This makes the test an excellent candidate for the use in clinical routine.”
Schulz et al. Clinical Laboratory 2016.